EQT and others sell remaining stake in Galderma
Published on 03/11/2026 at 04:56 am EDT
Contact us to request a correction
The transaction involved a total of 34 million shares sold at 143.75 Swiss francs per share, representing a discount of just over 7 percent compared to Galderma's last closing price. Galderma is repurchasing 1.6 million shares as part of the deal.
The sale generates 4.9 billion Swiss francs for the sellers, equivalent to nearly 58 billion Swedish kronor.
The owners' exit follows a strong performance by Galderma since its initial public offering in the spring of 2024. EQT had previously reduced its holding in the company.

















